Our study agrees with several recent investigations, which showed that the lower GABPA expression is correlated with bigger tumor sizes, advanced stages or grades, local and distant metastasis, and poor outcomes in patients with thyroid carcinoma, hepatocellular carcinoma, or bladder cancer [17, 18, 22]. This evidence concerns the gene GABPA and urinary bladder carcinoma.